Recombinant human thyroid-stimulating hormone (rhTSH): clinical development.

@article{Incerti1999RecombinantHT,
  title={Recombinant human thyroid-stimulating hormone (rhTSH): clinical development.},
  author={Claudia Incerti},
  journal={Journal of endocrinological investigation},
  year={1999},
  volume={22 11 Suppl},
  pages={
          8-16
        }
}
Recombinant human thyroid-stimulating hormone (rhTSH) was developed to safely provide exogenous TSH stimulation in patients on thyroid hormone suppression therapy (THST), which is integral to long-term management of well-differentiated thyroid cancer. Such stimulation allows detection of thyroid remnant and neoplastic tissue by serum thyroglobulin (Tg) testing and/or diagnostic iodine-131 (I-131) imaging, sparing patients THST withdrawal and resultant metabolic impairment, discomfort and… CONTINUE READING